Literature DB >> 17149430

The chemically elegant proton pump inhibitors.

Victoria F Roche1.   

Abstract

Medicinal chemistry instruction at Creighton University is designed to provide an in-depth scientifically grounded and clinically relevant learning experience for pharmacy students. Each topic covered in the 2-semester required course sequence is selected based on the general utility of the compounds in question and/or the therapeutic importance of the drugs in treating life-threatening diseases. All lessons provided to campus- and Web-based students by the author are in the form of a descriptive and conversational narrative and course requirements are in place to assure that students read the lesson prior to the class period in which it is discussed. Learning tools and aids are provided to help students more readily discern the most critical aspects of each lesson, to practice required critical thinking and structure analysis skills, and to self-assess competency in meeting specific learning objectives. This manuscript illustrates this approach by sharing a lesson on the chemistry and clinically relevant structure-activity relationships of proton pump inhibitors.

Mesh:

Substances:

Year:  2006        PMID: 17149430      PMCID: PMC1637016          DOI: 10.5688/aj7005101

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  7 in total

Review 1.  Pharmacogenetics of the proton pump inhibitors: a systematic review.

Authors:  Elaine Chong; Mary H H Ensom
Journal:  Pharmacotherapy       Date:  2003-04       Impact factor: 4.705

Review 2.  Proton pump inhibitors and their drug interactions: an evidence-based approach.

Authors:  L B Gerson; G Triadafilopoulos
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 2.566

Review 3.  Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.

Authors:  J Horn
Journal:  Aliment Pharmacol Ther       Date:  2004-11       Impact factor: 8.171

4.  Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors.

Authors:  Tomoko Kita; Toshiyuki Sakaeda; Takahiko Baba; Nobuo Aoyama; Mikio Kakumoto; Yoshie Kurimoto; Yuko Kawahara; Noboru Okamura; Shirou Kirita; Masato Kasuga; Katsuhiko Okumura
Journal:  Biol Pharm Bull       Date:  2003-03       Impact factor: 2.233

Review 5.  Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

Authors:  Malcolm Robinson; John Horn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors.

Authors:  Bjarni Thjodleifsson
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.

Authors:  Jai Moo Shin; Young Moon Cho; George Sachs
Journal:  J Am Chem Soc       Date:  2004-06-30       Impact factor: 15.419

  7 in total
  19 in total

1.  Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?

Authors:  Amir H Zargarzadeh; Susan Jacob; Roger S Klotz; Fadi T Khasawneh
Journal:  Int J Clin Pharm       Date:  2011-12

2.  Science-based pharmacy education.

Authors:  David W Newton
Journal:  Am J Pharm Educ       Date:  2007-04-15       Impact factor: 2.047

3.  A receptor-grounded approach to teaching nonsteroidal antiinflammatory drug chemistry and structure-activity relationships.

Authors:  Victoria F Roche
Journal:  Am J Pharm Educ       Date:  2009-12-17       Impact factor: 2.047

4.  Design and implementation of a laboratory-based drug design and synthesis advanced pharmacy practice experience.

Authors:  Ashok Philip; Mark Stephens; Sheila L Mitchell; E Blake Watkins
Journal:  Am J Pharm Educ       Date:  2015-04-25       Impact factor: 2.047

5.  Creation of medicinal chemistry learning communities through enhanced technology and interdisciplinary collaboration.

Authors:  Brian Henriksen; Victoria Roche
Journal:  Am J Pharm Educ       Date:  2012-10-12       Impact factor: 2.047

Review 6.  Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.

Authors:  V Shakhnovich; R M Ward; G L Kearns
Journal:  Clin Pharmacol Ther       Date:  2012-07-18       Impact factor: 6.875

7.  Selective inactivation of a human neuronal silencing phosphatase by a small molecule inhibitor.

Authors:  Mengmeng Zhang; Eun Jeong Cho; Gayle Burstein; Dionicio Siegel; Yan Zhang
Journal:  ACS Chem Biol       Date:  2011-02-24       Impact factor: 5.100

8.  Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.

Authors:  Mary S Matsui; Michael J Petris; Yoko Niki; Nevena Karaman-Jurukovska; Neelam Muizzuddin; Masamitsu Ichihashi; Daniel B Yarosh
Journal:  J Invest Dermatol       Date:  2014-10-22       Impact factor: 8.551

Review 9.  Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence.

Authors:  Yuko Akazawa; Daisuke Fukuda; Yutaka Fukuda
Journal:  Therap Adv Gastroenterol       Date:  2016-09-22       Impact factor: 4.409

10.  Improving pharmacy students' understanding and long-term retention of acid-base chemistry.

Authors:  Victoria F Roche
Journal:  Am J Pharm Educ       Date:  2007-12-15       Impact factor: 2.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.